AJCC TUMOR REGRESSION GRADE 3 STRONGLY PREDICTS RECURRENCE AMONG YPT3 RECTAL CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMORADIATION.

被引：0
|
作者：
Mills, M.
Frakes, J.
Moore, M.
Lauwers, G.
Hoffe, S.
Dessureault, S.
Sanchez, J.
Felder, S.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2021年 / 64卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
POD296
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
    L. Shen
    L. Wang
    G. Li
    H. Zhang
    L. Liang
    M. Fan
    Y. Wu
    W. Deng
    W. Sheng
    J. Zhu
    Z. Zhang
    Clinical and Translational Oncology, 2016, 18 : 693 - 699
  • [2] Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
    Shen, L.
    Wang, L.
    Li, G.
    Zhang, H.
    Liang, L.
    Fan, M.
    Wu, Y.
    Deng, W.
    Sheng, W.
    Zhu, J.
    Zhang, Z.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (07): : 693 - 699
  • [3] Can Tumor Regression Grade Influence Survival Outcome in ypT3 Rectal Cancer?
    Shen, L.
    Wang, L.
    Zhu, J.
    Li, G.
    Liang, L.
    Zhang, H.
    Zhang, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E124 - E125
  • [4] The use of personalized biomarkers for accessing tumor regression and defining surgical approach in rectal cancer patients treated with neoadjuvant chemoradiation.
    Garpinetti, Paola
    Donnard, Elisa
    Asprino, Paula
    Bettoni, Fabiana
    Koyama, Fernanda
    Habr-Gama, Angelita
    Parmigiani, Raphael
    Galante, Pedro
    Perez, Rodrigo
    Camargo, Anamaria A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [5] Severe lymphopenia predicts poorer survival in patients with rectal cancer undergoing neoadjuvant chemoradiation.
    Kim, Daniel W.
    Lee, Grace
    Weekes, Colin D.
    Ryan, David P.
    Parikh, Aparna Raj
    Allen, Jill N.
    Giantonio, Bruce J.
    Berger, David L.
    Kunitake, Hiroko
    Ricciardi, Rocco
    Cusack, James C.
    Hwang, William L.
    Hong, Theodore S.
    Wo, Jennifer Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [6] SARCOPENIA AMONG RECTAL CANCER PATIENTS IS MORE COMMON FOLLOWING NEOADJUVANT CHEMORADIATION.
    Bliggenstorfer, J. T.
    Hashmi, A.
    Ginesi, M. C.
    Paspulati, R.
    Stein, S. L.
    Steinhagen, E.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
  • [7] The prognostic role of the host immune response in rectal cancer patients treated with neoadjuvant chemoradiation.
    Sprenger, Thilo
    Wirtz, Ralph M.
    Pektas, Selcan
    Bohnenberger, Hanibal
    Kauffels, Anne
    Conradi, Lena-Christin
    Homayounfar, Kia
    Liersch, Torsten
    Ghadimi, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [8] Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation
    Yang, Fan
    Hill, Jordan
    Abraham, Aswin
    Ghosh, Sunita
    Steed, Tanner
    Kurtz, Clay
    Joseph, Kurian
    Yun, Jihyun
    Warkentin, Brad
    Thai, JoAnn
    Nijjar, Tirath
    Severin, Diane
    Tankel, Keith
    Fairchild, Alysa
    Usmani, Nawaid
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (10): : 405 - 409
  • [9] Tumor Volume Predicts for Pathological Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation
    Hill, J.
    Yang, F.
    Abraham, A.
    Ghosh, S.
    Steed, T. M.
    Kurtz, C.
    Joseph, K. J.
    Yun, J.
    Nijjar, T.
    Severin, D. M.
    Tankel, K.
    Fairchild, A. M.
    Usmani, N. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E44 - E44
  • [10] Clinical outcomes in elderly rectal cancer patients treated with neoadjuvant chemoradiotherapy: impact of tumor regression grade Tumor regression grade after neoadjuvant chemoradiotherapy in elderly rectal cancer patients
    Rosa, Consuelo
    Di Tommaso, Monica
    Caravatta, Luciana
    Taraborrelli, Maria
    Gasparini, Lucrezia
    Di Guglielmo, Fiorella Cristina
    Pizzi, Andrea Delli
    Cinalli, Sebastiano
    Marchioni, Michele
    Di Nicola, Marta
    Lanci, Carmine
    Cefaro, Giampiero Ausili
    Genovesi, Domenico
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (04) : 1179 - 1188
12345